{"disease":{"id":"subclinical-atherosclerotic-cardiovascular-disease","name":"subclinical atherosclerotic cardiovascular disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03225196","title":"Extracellular RNAs in Relation to Cardiometabolic Risk","phase":"","overall_status":"COMPLETED","enrollment_count":4495,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07520643","title":"MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07524335","title":"Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Montreal Heart Institute","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}